Decoding autoimmunity.
Neural Omega is rebuilding the infrastructure of autoimmune medicine — across patient care, clinical practice, research, and drug discovery. Four products. Two verticals. One European foundation.
A hundred diseases. One fragmented system.
Healthcare treats autoimmune disease as dozens of isolated conditions that don't share data, vocabulary, or infrastructure. Patients wait years for a diagnosis. Clinicians decide with partial information. Researchers work on cohorts too small to detect what matters. The same problem, seen from every angle.
Four products. Two verticals. One foundation.
A patient app, a clinical tool, a research platform and a drug discovery engine — operating on a single European data infrastructure. Each vertical has its own audience and its own roadmap. The architecture beneath them is one.
Four decisions that change what's possible.
The differentiators that no competitor based outside Europe can replicate with credibility — and that no generic healthtech platform has built into its foundation.
Apple-native, offline-first
Works where clinicians actually work — consultations without signal, hospitals with restricted networks, professional devices already in the healthcare ecosystem.
EHDS-ready by design
Built under GDPR. Aligned with FHIR and OMOP. Architected for the European Health Data Space coming into force in 2029. Not a retrofit — the foundation.
Clinical independence
Patient-facing and clinician-facing products take no pharma funding and sell no patient data. The patient and the clinician come first, always.
Built in Madrid, made for Europe
Spanish company. Madrid team. European infrastructure. Member of AseBio, backed by ENISA and NextGenerationEU.
One phenomenon. Four altitudes.
Molecular mimicry runs through the whole of autoimmune disease — from the person who lives it to the therapy that may one day correct it. One signal, read at four altitudes.
Long-form thinking on autoimmune medicine.
We publish original research and analysis on the structural problems we're working to solve. Not marketing — thinking that gets cited.
The diagnostic gap: why autoimmune patients still wait years for an answer
An examination of the structural reasons behind delayed autoimmune diagnosis in Europe — and what would have to change in the data layer of the health system to close it.
Read the essay →BioSpain 2026
If you want to see what we are building in person, meet the team, and discuss partnerships — this is where to find us.
Request a meeting →